<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32314541</article-id>
<article-id pub-id-type="pmc">7284031</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.1234</article-id>
<article-id pub-id-type="publisher-id">MGG31234</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A novel <italic>PCDH19</italic> missense mutation, c.812G&gt;A (p.Gly271Asp), identified using whole‐exome sequencing in a Chinese family with epilepsy female restricted mental retardation syndrome</article-title>
<alt-title alt-title-type="left-running-head">ZHAO et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mgg31234-cr-0001">
<name>
<surname>Zhao</surname>
<given-names>Xuechao</given-names>
</name>
<xref ref-type="aff" rid="mgg31234-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31234-cr-0002">
<name>
<surname>Wang</surname>
<given-names>Yanhong</given-names>
</name>
<xref ref-type="aff" rid="mgg31234-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31234-cr-0003">
<name>
<surname>Mei</surname>
<given-names>Shiyue</given-names>
</name>
<xref ref-type="aff" rid="mgg31234-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg31234-cr-0004">
<name>
<surname>Kong</surname>
<given-names>Xiangdong</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5685-8055</contrib-id>
<xref ref-type="aff" rid="mgg31234-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>kxd1968@163.com</email>
</address>
</contrib>
</contrib-group>
<aff id="mgg31234-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Genetics and Prenatal Diagnosis Center</named-content>
<institution>The First Affiliated Hospital of Zhengzhou University</institution>
<institution>Henan Engineering Research Center for Gene Editing of Human Genetic Disease, Erqi District</institution>
<city>Zhengzhou</city>
<country country="CN">People's Republic of China</country>
</aff>
<aff id="mgg31234-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Henan provincial key laboratory of children's genetics and metabolic diseases</named-content>
<institution>Children's Hospital Affiliated to Zhengzhou University</institution>
<institution>Zhengzhou Children's Hospital, Zhengzhou</institution>
<city>Zhengzhou</city>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Xiangdong Kong, Genetics and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Gene Editing of Human Genetic Disease, Jianshe Rd, Erqi District, Zhengzhou, Henan 450052, People's Republic of China.<break></break>
Email: <email>kxd1968@163.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>8</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.v8.6</issue-id>
<elocation-id>e1234</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>1</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2020 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals LLC</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-8-e1234.pdf"></self-uri>
<abstract id="mgg31234-abs-0001">
<title>Abstract</title>
<sec id="mgg31234-sec-0001">
<title>Background</title>
<p>Epilepsy limited to females with mental retardation (EFMR) is a rare type of epilepsy with an X‐linked mode of inheritance, which affect heterozygous females while the males are not affected. Mutations within the protocadherin 19 (<italic>PCDH19</italic>) gene have been identified as the direct cause of EFMR. The phenotype of EFMR is characterized by seizure onset in infancy with or without cognitive impairment, intellectual disturbances, and autistic features.</p>
</sec>
<sec id="mgg31234-sec-0002">
<title>Methods</title>
<p>Whole‐exome sequencing (WES) was performed in the proband to identify the underlying genetic mutations. The candidate genes were confirmed by Sanger sequencing following PCR amplification. In silico analyses were conducted to predict the effect of the novel missense mutation on the function of PCDH19 protein.</p>
</sec>
<sec id="mgg31234-sec-0003">
<title>Results</title>
<p>We identified three female patients in a family with a novel missense mutation in <italic>PCDH19</italic>, c.812G&gt;A (p. (Gly271Asp)). The patients III‐1 and III‐2 presented with more severe clinical phenotypes and an earlier age of onset (6 and 11 months, respectively), intellectual disability, and movement disorders. By contrast, patient II‐4 has a later age of onset (23 months), and there was no relapse of seizures without antiepileptic treatment after the age of six. In silico analyses showed that p. (Gly271Asp) in the <italic>PCDH19</italic> affects a highly conserved residue.</p>
</sec>
<sec id="mgg31234-sec-0004">
<title>Conclusions</title>
<p>Our results indicated that patients with the same <italic>PCDH19</italic> mutation in a family may show intrafamilial phenotypic variability. Givening the mother of the proband was 18 weeks pregnant and intends to have a prenatal diagnosis, the more reasonable and less harmful strategies for prenatal diagnosis could be chosen based on the results of noninvasive prenatal testing and genetic testing.</p>
</sec>
</abstract>
<abstract abstract-type="graphical" id="mgg31234-abs-0002">
<p>We have presented three patients in a family with clinical presentation of EFMR having one new PCDH19 mutation (c.812G&gt;A (p. (Gly271Asp))) not previously described in the scientific literature. It provides important information for genetic counseling in this family.<boxed-text content-type="graphic" id="mgg31234-blkfxd-0001" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="MGG3-8-e1234-g004.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group>
<kwd id="mgg31234-kwd-0001">epilepsy</kwd>
<kwd id="mgg31234-kwd-0002">missense mutation</kwd>
<kwd id="mgg31234-kwd-0003"><italic>PCDH19</italic> gene</kwd>
<kwd id="mgg31234-kwd-0004">prenatal diagnosis</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>National Natural Science Fundation of China</funding-source>
<award-id>81701125</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="3"></table-count>
<page-count count="7"></page-count>
<word-count count="4271"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:10.06.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg31234-cit-1001" publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mei</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>X</given-names>
</string-name>. <article-title>A novel <italic>PCDH19</italic> missense mutation, c.812G&gt;A (p.Gly271Asp), identified using whole‐exome sequencing in a Chinese family with epilepsy female restricted mental retardation syndrome</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2020</year>;<volume>8</volume>:<elocation-id>e1234</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.1234</pub-id>
</mixed-citation>
</p>
<fn-group id="mgg31234-ntgp-0001">
<fn fn-type="funding" id="mgg31234-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>This work was supported by the National Natural Science Foundation of China [grant number 81701125].</p>
</fn>
</fn-group>
</notes>
</front>
<body id="mgg31234-body-0001">
<sec id="mgg31234-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Epilepsy and mental retardation limited to females (EFMR; MIM300088) is a disorder with an X‐linked mode of inheritance and an unusual sex‐limited expression pattern. Different from the classic X‐linked pattern characterized by affected males and unaffected carrier females, the females affected by EFMR are connected through unaffected males. In 1971, Juberg and Hellman first reported the EFMR pattern, with main clinical features including an early infantile onset of seizures with or without cognitive impairment, intellectual disturbances, and resistance to antiepileptic drugs (Juberg &amp; Hellman, <xref ref-type="ref" rid="mgg31234-bib-0009">1971</xref>; Smith et al., <xref ref-type="ref" rid="mgg31234-bib-0022">2018</xref>; Yang et al., <xref ref-type="ref" rid="mgg31234-bib-0026">2019</xref>). Patients often display fever‐related seizures which typically cluster, and the types are diverse, including tonic, clonic or tonic–clonic, and partial seizures (Juberg &amp; Hellman, <xref ref-type="ref" rid="mgg31234-bib-0009">1971</xref>; Marini et al., <xref ref-type="ref" rid="mgg31234-bib-0014">2012</xref>).</p>
<p>Dibbens et al., (<xref ref-type="ref" rid="mgg31234-bib-0007">2008</xref>) first reported that <italic>PCDH19</italic> (MIM: 300088) gene mutations were associated with EFMR. The <italic>PCDH19</italic> gene is located at Xq22 and is composed of six exons which encode an 1148‐amino‐acid protein belonging to the protocadherin (PCDH) δ2 subgroup within the cadherin superfamily of cell–cell adhesion molecules(Dibbens et al., <xref ref-type="ref" rid="mgg31234-bib-0007">2008</xref>). PCDH19 contains a signal sequence at its N‐terminus, six extracellular cadherin (EC) repeats, a transmembrane domain, and a cytoplasmic region with conserved CM1 and CM2 domains. PCDH is predominantly expressed in the nervous system and may play a role in the development of neuronal connections and signal transduction at the synaptic membrane (Bassani et al., <xref ref-type="ref" rid="mgg31234-bib-0002">2018</xref>; Compagnucci et al., <xref ref-type="ref" rid="mgg31234-bib-0004">2015</xref>; Kurian et al., <xref ref-type="ref" rid="mgg31234-bib-0011">2018</xref>; Pederick et al., <xref ref-type="ref" rid="mgg31234-bib-0016">2018</xref>).</p>
<p>With the development of next‐generation sequencing technology, the number of diagnosed cases of <italic>PCDH19</italic>‐related epilepsy is increasing since 2008. According to the Human Gene Mutation Database (HGMD: <ext-link ext-link-type="uri" xlink:href="http://hgmd.cf.ac.uk">http://hgmd.cf.ac.uk</ext-link>, 2019.4), 283 different mutations of the <italic>PCDH19</italic> genes have been reported, 172 of which are missense and nonsense mutations. Here, we report three female patients from a Chinese family presenting with epilepsy due to a missense mutation (G to A transversion at position 812 in exon 1) of <italic>PCDH19</italic>. Since the mother of the proband was pregnant for 18 weeks, our results provided important information for prenatal genetic counseling of the family.</p>
</sec>
<sec id="mgg31234-sec-0006" sec-type="materials-and-methods">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="mgg31234-sec-0007">
<label>2.1</label>
<title>Ethical compliance</title>
<p>The study and procedures were approved by the Research Ethics Committee of Zhengzhou University. The subjects gave informed signed consents.</p>
</sec>
<sec id="mgg31234-sec-0008">
<label>2.2</label>
<title>Samples and DNA extraction</title>
<p>Genomic DNA was extracted from EDTA peripheral blood samples using a Lab‐Aid<sup>®</sup> 824 DNA Extraction Kit (ZEESAN), according to the manufacturer's protocol.</p>
</sec>
<sec id="mgg31234-sec-0009">
<label>2.3</label>
<title>Whole‐exome sequencing</title>
<p>First, 1 μg of genomic DNA was fragmented to an average size of 200 bp using a Biorupter UCD‐200 (Diagenode). The DNA fragments were then end‐repaired, and an A was added to the 3'end. Second, the DNA fragments were connected with sequencing adaptors, and fragments of approximately 320 bp were collected using XP beads. After PCR amplification, the DNA fragments were hybridized and captured using the IDT's xGen Exome Research Panel (Integrated DNA Technologies) according to the manufacturer's protocol. The hybrid products were eluted and collected. Then the DNA was PCR amplified and purified. Next, the libraries were tested for enrichment by qPCR, and their size distribution and concentration were determined using an Agilent Bioanalyzer 2100 (Agilent Technologies). Finally, a Novaseq6000 platform (Illumina), with 150‐bp paired‐end reads was used for sequencing the genomic DNA of the family. Raw image files were processed using CASAVA v1.82 for base calling and generating raw data.</p>
<p>The sequencing reads were aligned to the human reference genome (hg19/GRCh37) using the Burrows–Wheeler Aligner tool, and PCR duplicates were removed using Picard v1.57 (<ext-link ext-link-type="uri" xlink:href="http://picard.sourceforge.net/">http://picard.sourceforge.net/</ext-link>). The Verita Trekker® Variants Detection System by Berry Genomics and the third‐party software GATK (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/gatk/">https://software.broadinstitute.org/gatk/</ext-link>) were employed for variant calling. Variant annotation and interpretation were conducted using ANNOVAR (Wang, Li, &amp; Hakonarson, <xref ref-type="ref" rid="mgg31234-bib-0025">2010</xref>) and the Enliven® Variants Annotation Interpretation System authorized by Berry genomics. The variants were classified into the five categories—“pathogenic,” “likely pathogenic,” “uncertain significance,” “likely benign,” and “benign”—according to the American College of Medical Genetics and Genomics (ACMG) guidelines for interpretation of genetic variants (Richards et al., <xref ref-type="ref" rid="mgg31234-bib-0018">2015</xref>). Variants with minor allele frequencies (MAF) &lt;1% in exonic regions or with splicing impact were taken for deep interpretation considering ACMG category, evidence of pathogenicity and clinical synopsis, and inheritance model of the associated disease. Annotated whole‐exome sequencing (WES) data were examined for variants in 100 genes selected for relevance for the epilepsy phenotypes (Lindy et al., <xref ref-type="ref" rid="mgg31234-bib-0012">2018</xref>): <italic>SCN1A</italic>, <italic>KCNQ2</italic>, <italic>CDKL5</italic>, <italic>SCN2A</italic>, <italic>PRRT2</italic>, <italic>PCDH19</italic>, <italic>STXBP1</italic>, <italic>SLC2A1</italic>, <italic>GABRG2</italic>, <italic>SCN8A</italic>, UBE3A, <italic>MECP2</italic>, <italic>GRIN2A</italic>, <italic>TSC2</italic>, <italic>FOXG1</italic>, <italic>GABRA1</italic>, <italic>TPP1</italic>, <italic>ZEB2</italic>, <italic>CHRNA4</italic>, <italic>ARX</italic>, <italic>TSC1</italic>, <italic>ALDH7A1</italic>, <italic>CHRNA7</italic>, <italic>TCF4</italic>, <italic>POLG</italic>, <italic>SLC9A6</italic>, <italic>SCN1B</italic>, <italic>MEF2C</italic>, <italic>SPTAN1</italic>, <italic>EPM2A</italic>, <italic>PNPO</italic>, <italic>MBD5</italic>, <italic>KCNQ3</italic>, <italic>TBC1D24</italic>, <italic>CLN5</italic>, <italic>ATP1A2</italic>, <italic>LGI1</italic>, <italic>KANSL1</italic>, <italic>GAMT</italic>, <italic>GRIN2B</italic>, <italic>CLN6</italic>, <italic>CLN3</italic>, <italic>CNTNAP2</italic>, <italic>CHRNB2</italic>, <italic>NHLRC1</italic>, <italic>KCNJ10</italic>, <italic>PNKP</italic>, <italic>PPT1</italic>, <italic>SCARB2</italic>, <italic>ADSL</italic>, <italic>MFSD8</italic>, <italic>SYN1</italic>, <italic>KCTD7</italic>, <italic>CLN8</italic>, <italic>ATP6AP2</italic>, <italic>CACNB4</italic>, <italic>CHRNA2</italic>, <italic>CSTB</italic>, <italic>CTSD</italic>, <italic>DNAJC5</italic>, <italic>EFHC1</italic>, <italic>FOLR1</italic>, <italic>GATM</italic>, <italic>GOSR2</italic>, <italic>LIAS</italic>, <italic>MAGI2</italic>, <italic>NRXN1</italic>, <italic>PRICKLE1</italic>, <italic>SLC25A22</italic>, <italic>SRPX2, HNRNPU</italic>, <italic>CACNA1A, ST3GAL2,CNTN5, CASK, NEDD4L, ARHGEF9, MAPK10</italic>
<italic>, IQSEC2, GABRA6, TBC1D24, SZT2, PLCB1, CLCN2, SLC2A1, ME2, ARHGEF15, CLCN4, DNM1, KCNH5, EEF1A2, RYR3, FASN, GABBR2, KCNB1, DOCK7, SLC13A5, CHD2, VRK2, KCNMA1</italic>. Variants identified using WES were confirmed by Sanger sequencing.</p>
</sec>
</sec>
<sec id="mgg31234-sec-0010" sec-type="results">
<label>3</label>
<title>RESULTS</title>
<sec id="mgg31234-sec-0011">
<label>3.1</label>
<title>Case report</title>
<p>The proband (III‐1) was a 9‐year‐old girl, who suffered from repetitive seizures for more than 8 years. The disease onset was at 6 months and the symptoms included predominantly generalized tonic–clonic seizures. The seizures recurred with a fever and frequently lasted for 4 to 6 days. Magnetic resonance imaging (MRI) was normal and the electroencephalogram (EEG) showed nonspecific slow waves. In infancy, she showed normal early developmental milestones, but later exhibited signs of intellectual disability (ID) and autism. She was inattentive, very impulsive, and prone to crying. When running or going up and down the stairs, she walked unsteadily and would frequently fall. Although she received antiepileptic treatments, including levetiracetam, sodium valproate, carbamazepine, and topiramate, the treatment effects were limited. The patient III‐2 was a 13‐year‐old girl and her seizure onset was at 11 months. The other symptoms were similar to those of the proband III‐1, such as intellectual disability (ID), autism, and resistance to antiepileptic drugs (Table <xref ref-type="table" rid="mgg31234-tbl-0001">1</xref>). The patient II‐4, who was the mother of proband III‐2, was a 40‐year‐old female and her seizure onset was at 23 months. Although she didn't receive antiepileptic treatments, her seizures had disappeared after 6 years old. She showed normal intelligence and had no signs of autism.</p>
<table-wrap content-type="TABLE" id="mgg31234-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>TABLE 1</label>
<caption>
<p>Clinical information of the three EFMR patients investigated in this case report</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patients features</th>
<th align="left" colspan="1" rowspan="1" valign="top">III‐1</th>
<th align="left" colspan="1" rowspan="1" valign="top">III‐2</th>
<th align="left" colspan="1" rowspan="1" valign="top">II‐4</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age at present age (years)</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">40</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age at seizure onset (months)</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">23</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Type of seizures at onset</td>
<td align="left" colspan="1" rowspan="1">GTCS</td>
<td align="left" colspan="1" rowspan="1">GTCS</td>
<td align="left" colspan="1" rowspan="1">TS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Presence of febrile seizures</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Absence</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cluster/repetitive</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GTC</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Myoclonic jerks</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Partial</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Status epilepticus</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Results of head MRI</td>
<td align="left" colspan="1" rowspan="1">N</td>
<td align="left" colspan="1" rowspan="1">NP</td>
<td align="left" colspan="1" rowspan="1">NP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Persistence of seizures in spite of treatment</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Intellectual disability</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Language delay</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Behavioral disturbances (Crying/Irritability/Outbursts)</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Autistic features</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Motor delay</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="mgg31234-ntgp-0002">
<fn id="mgg31234-note-0002">
<p>Abbreviations: GTCS, generalized tonic–clonic seizures; N, normal; NP, not performed;TS, tonic seizure.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="mgg31234-sec-0012">
<label>3.2</label>
<title>Whole‐exome sequencing revealed a novel <italic>PCDH19</italic> c.812G&gt;A (p. (Gly271Asp)) missense variant</title>
<p>Whole‐exome sequencing was performed on the proband (III‐1), and variant filtering was performed as described in the methods. Two non‐synonymous variants and one frameshift variant were identified in genes associated with epilepsy. One variant in the <italic>PCDH19</italic> (NM_001184880.1: c.812G&gt;A) was not previously reported in variant databases including NCBI dbSNP, 1000Genomes, gnomAD, and ExAC. Two additional variants were also considered because of their low minor allele frequency (MAF &lt; 0.1‰) (<italic>SCN1A</italic>, c.2378C&gt;T, NM_001165963 and <italic>HNRNPU</italic>, c.16_17delGT, NM_031844). Sanger sequencing confirmed the heterozygous c.812G&gt;A variant of the <italic>PCDH19</italic> in the proband III‐1, which was inherited from her unaffected father. The two affected female patients III‐2 and II‐4 in the family also carried heterozygous variation in <italic>PCDH19</italic> (Figure <xref ref-type="fig" rid="mgg31234-fig-0001">1</xref>). The variant c.2378C&gt;T of <italic>SCN1A</italic> in the proband was inherited from her unaffected mother. We did not find the c.16_17delGT variant in the <italic>HNRNPU</italic> by Sanger sequencing, and it was presumed to be a false positive of the WES technology (Table <xref ref-type="table" rid="mgg31234-tbl-0002">2</xref>). Considering the nontypical inherence mode of the family and the known association of <italic>PCDH19</italic> with EFMR, the <italic>PCDH19</italic> c.812G&gt;A variant was identified as the most promising candidate.</p>
<fig fig-type="FIGURE" id="mgg31234-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>FIGURE 1</label>
<caption>
<p>(a) Pedigree of the three‐generation kindred and associated <italic>PCDH19</italic> c.812G&gt;A genotypes. A solid circle denotes an affected female, an open circle denotes an unaffected female, and an open square with a small point denotes an unaffected male who is a carrier for the <italic>PCDH19</italic> c.812G&gt;A mutation. (b) Electropherograms of Sanger sequencing of the <italic>PCDH19</italic> confirming the c.812G&gt;A missense mutation</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-8-e1234-g001"></graphic>
</fig>
<table-wrap content-type="TABLE" id="mgg31234-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>TABLE 2</label>
<caption>
<p>Information of three candidate gene variants obtained after variant calling</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Transcript</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Sequencing depth</th>
<th align="left" colspan="1" rowspan="1" valign="top">Sanger sequencing</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mode of inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Source of variation</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>PCDH19</italic>
</td>
<td align="left" colspan="1" rowspan="1">NM_001184880.1</td>
<td align="left" colspan="1" rowspan="1">c.812G&gt;A</td>
<td align="left" colspan="1" rowspan="1">102/61</td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">XL</td>
<td align="left" colspan="1" rowspan="1">Epileptic encephalopathy, early infantile, 9 (OMIM:300088)</td>
<td align="left" colspan="1" rowspan="1">Father</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">NM_001165963</td>
<td align="left" colspan="1" rowspan="1">c.2378C&gt;T</td>
<td align="left" colspan="1" rowspan="1">27/27</td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">Dravet syndrome(OMIM:607208)</td>
<td align="left" colspan="1" rowspan="1">Mother</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HNRNPU</italic>
</td>
<td align="left" colspan="1" rowspan="1">NM_031844</td>
<td align="left" colspan="1" rowspan="1">c.16_17delGT</td>
<td align="left" colspan="1" rowspan="1">25/33</td>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">Epileptic encephalopathy, early infantile, 54(OMIM:617391)</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="mgg31234-ntgp-0003">
<fn id="mgg31234-note-0003">
<p>Abbreviations: AD, autosomal dominant;XL, X‐linked.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="mgg31234-sec-0013">
<label>3.3</label>
<title>In silico analyses showed that the p. (Gly271Asp) variant of <italic>PCDH19</italic> affects a highly conserved residue</title>
<p>The p. (Gly271Asp) mutation is located in the cadherin functional domain and amino acid sequence alignment showed that it occurs at a highly conserved residue in <italic>PCDH19</italic> with surrounding amino acid residues being conserved between orthologs (Figure <xref ref-type="fig" rid="mgg31234-fig-0002">2</xref>). The conservation of the Gly271 amino acid residue and pathogenicity of the p. (Gly271Asp) variant were predicted by multiple in silico analysis techniques (Table <xref ref-type="table" rid="mgg31234-tbl-0003">3</xref>). The scores obtained using PhyloP (Pollard, Hubisz, Rosenbloom, &amp; Siepel, <xref ref-type="ref" rid="mgg31234-bib-0017">2010</xref>) (<ext-link ext-link-type="uri" xlink:href="http://compgen.cshl.edu/phastweb/runtool.php">http://compgen.cshl.edu/phastweb/runtool.php</ext-link>), phastCons (Siepel et al., <xref ref-type="ref" rid="mgg31234-bib-0020">2005</xref>), and GERP (Davydov et al., <xref ref-type="ref" rid="mgg31234-bib-0005">2010</xref>) (<ext-link ext-link-type="uri" xlink:href="http://mendel.stanford.edu/sidowlab/downloads/gerp/index.html">http://mendel.stanford.edu/sidowlab/downloads/gerp/index.html</ext-link>) demonstrated that the Gly271 amino acid residue was highly evolutionarily constrained. Furthermore, the Polyphen2 (Adzhubei et al., <xref ref-type="ref" rid="mgg31234-bib-0001">2010</xref>) (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), PROVEAN (Choi, Sims, Murphy, Miller, &amp; Chan, <xref ref-type="ref" rid="mgg31234-bib-0003">2012</xref>) (<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/seq_submit.php">http://provean.jcvi.org/seq_submit.php</ext-link>), SIFT (Sim et al., <xref ref-type="ref" rid="mgg31234-bib-0021">2012</xref>) (<ext-link ext-link-type="uri" xlink:href="https://sift.bii.a-star.edu.sg/www/SIFT_seq_submit2.html">https://sift.bii.a‐star.edu.sg/www/SIFT_seq_submit2.html</ext-link>), and MutationTaster2 (Schwarz, Cooper, Schuelke, &amp; Seelow, <xref ref-type="ref" rid="mgg31234-bib-0019">2014</xref>) (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/">http://www.mutationtaster.org/</ext-link>) scores indicated that the functional effect of the p. (Gly271Asp) variant was damaging (Table <xref ref-type="table" rid="mgg31234-tbl-0003">3</xref>).</p>
<fig fig-type="FIGURE" id="mgg31234-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>FIGURE 2</label>
<caption>
<p>Alignment of the p. (Gly271Asp) mutation with <italic>PCDH19</italic> orthologs in different vertebrate species. Position 271 is indicated by the red box</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="MGG3-8-e1234-g002"></graphic>
</fig>
<table-wrap content-type="TABLE" id="mgg31234-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>TABLE 3</label>
<caption>
<p>The pathogenicity of the <italic>PCDH19</italic>, p. (Gly271Asp) variant was supported by multiple in silico analyses</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Method</th>
<th align="left" colspan="1" rowspan="1" valign="top">Score</th>
<th align="left" colspan="1" rowspan="1" valign="top">Prediction</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">PhyloP</td>
<td align="left" colspan="1" rowspan="1">7.892</td>
<td align="left" colspan="1" rowspan="1">Conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">phastCons</td>
<td align="left" colspan="1" rowspan="1">1.000</td>
<td align="left" colspan="1" rowspan="1">Conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GERP++</td>
<td align="left" colspan="1" rowspan="1">5.95</td>
<td align="left" colspan="1" rowspan="1">Conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Polyphen‐2_HDIV</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">Probably_damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Polyphen‐2_HVAR</td>
<td align="left" colspan="1" rowspan="1">1.0</td>
<td align="left" colspan="1" rowspan="1">Probably_damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mutation Taster</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Disease_causing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SIFT</td>
<td align="left" colspan="1" rowspan="1">0.0</td>
<td align="left" colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PROVEAN</td>
<td align="left" colspan="1" rowspan="1">−5.89</td>
<td align="left" colspan="1" rowspan="1">Damaging</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
</sec>
<sec id="mgg31234-sec-0014" sec-type="discussion">
<label>4</label>
<title>DISCUSSIONS</title>
<p>According to the clinical manifestations, genetic testing report, and the typical pedigree, the proband in this family was diagnosed as having EFMR resulting from a <italic>PCDH19</italic> c.812G&gt;A variant. The female children with the <italic>PCDH19</italic> mutation showed phenotypic diversity. Most EFMR patients show epilepsy with or without mental retardation, and some share certain features with the Dravet syndrome (DS), caused by mutations in <italic>SCN1A</italic>. These common features include early onset in infancy, fever sensitivity, cognitive impairment, and resistance to antiepileptic treatment (Liu et al., <xref ref-type="ref" rid="mgg31234-bib-0013">2017</xref>; Trivisano et al., <xref ref-type="ref" rid="mgg31234-bib-0024">2016</xref>). Additionally, a few female family members with the <italic>PCDH19</italic> mutation may have fever convulsions or normal phenotypes (Depienne et al., <xref ref-type="ref" rid="mgg31234-bib-0006">2009</xref>; Marini et al., <xref ref-type="ref" rid="mgg31234-bib-0015">2010</xref>). The age of onset of <italic>PCDH19</italic>‐related epilepsy ranges between 1and 70 months, with a median of 10 months (Dibbens et al., <xref ref-type="ref" rid="mgg31234-bib-0007">2008</xref>; Kolc et al., <xref ref-type="ref" rid="mgg31234-bib-0010">2019</xref>). In this family, the patients III‐1 and III‐2 displayed more severe clinical phenotypes with earlier onset age (6 and 11 months, respectively), intellectual disability, behavioral disturbances, and movement disorders (Table <xref ref-type="table" rid="mgg31234-tbl-0001">1</xref>). By contrast, the onset age for patient II‐4 was later (23 months), she did not have other disorders, and there was no relapse of seizures after the age of six, even without antiepileptic treatment. Thus, our results indicate that patients with the same <italic>PCDH19</italic> mutation may show intrafamilial phenotypic variability.</p>
<p>The <italic>PCDH19</italic> gene consists of 6 exons, whereby the first one encodes the transmembrane domain and the entire extracellular domain of the protein (Dibbens et al., <xref ref-type="ref" rid="mgg31234-bib-0007">2008</xref>), which plays an important role for the normal cadherin function (Figure <xref ref-type="fig" rid="mgg31234-fig-0003">3a</xref>). Reported mutations of the <italic>PCDH19</italic> gene are most commonly located in exon1, and are extremely rare in exon 2–6. The Human Gene Mutation Database (HGMD: <ext-link ext-link-type="uri" xlink:href="http://hgmd.cf.ac.uk">http://hgmd.cf.ac.uk</ext-link>, 2019.4), contains 283 different mutations of the <italic>PCDH19</italic>, including 172 missense/nonsense mutations, 48 small deletions, 30 small insertions, 8 small indels, 6 splicing mutations, 1 duplication, and 18 large fragment deletions. Among the 258 small variations (small deletions, small insertions, small indels, and missense/nonsense mutations), 235 (91%) were located in exon 1 (Figure <xref ref-type="fig" rid="mgg31234-fig-0003">3b</xref>).</p>
<fig fig-type="FIGURE" id="mgg31234-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>FIGURE 3</label>
<caption>
<p>(a) Schematic representation of the structure of the <italic>PCDH19</italic> mRNA and protein. Square indicate the point mutations identified in the three EFMR females. SP, signal peptide; EC, extracellular cadherin domain; TM, transmembrane domain; CM1 and CM2, cytoplasmic domains 1 and 2. The figure is adapted from Depienne et al. (<xref ref-type="ref" rid="mgg31234-bib-0006">2009</xref>). (b) The number of reported <italic>PCDH19</italic> exon 1–6 variants (small deletions, small insertions, small indels, and missense/nonsense mutations) in the HGMD</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="MGG3-8-e1234-g003"></graphic>
</fig>
<p>In this family, we found the novel missense mutation p. (Gly271Asp) in the <italic>PCDH19</italic>, which was also located in exon 1 and the genotypes corresponded to the atypical phenotypes of EFMR (affected female and unaffected males). This variant can be classified as “likely pathogenic” according to guidelines determined by the American College of Medical Genetics and Genomics (PM1 + PM2 + PP3 + PP4).</p>
<p>The unique sex‐limited expression pattern of EFMR may be explained by a “cellular interference” model (Depienne et al., <xref ref-type="ref" rid="mgg31234-bib-0006">2009</xref>; Dibbens et al., <xref ref-type="ref" rid="mgg31234-bib-0007">2008</xref>). The X‐inactivation in females heterozygous for a <italic>PCDH19</italic> mutation would lead to the coexistence of two cell populations (expressing wild‐type and mutated PCDH19), which may interfere with cell–cell interaction thus manifesting clinically as EFMR. By contrast, normal individuals and hemizygous carrier males with homogeneous cell populations would not develop the disease (Jamal, Basran, Newton, Wang, &amp; Milunsky, <xref ref-type="ref" rid="mgg31234-bib-0008">2010</xref>). This hypothesis was supported by the report that two symptomatic males carried two mosaic <italic>PCDH19</italic> point mutations (Terracciano et al., <xref ref-type="ref" rid="mgg31234-bib-0023">2016</xref>). In this family, the father of proband III‐1 was asymptomatic because of a hemizygous mutation in <italic>PCDH19</italic>.</p>
<p>Because of the atypical symptoms of EFMR, genetic testing plays an important role in the diagnosis. The mother of the proband was 18 weeks pregnant and intended to have a prenatal diagnosis. The noninvasive prenatal testing indicated that the fetus is a boy, and the X chromosome of the fetus comes from the mother, did not carry the p. (Gly271Asp) mutation in the <italic>PCDH19</italic> gene. Consequently, we did not recommend an interventional prenatal diagnosis for this family.</p>
<p>In conclusion, we identified three patients in a family with clinical presentation of EFMR having a new <italic>PCDH19</italic> mutation not previously described in the scientific literature. The study provides important information for genetic counseling in this family and enriches our knowledge of mutations that can cause EFMR.</p>
</sec>
<sec id="mgg31234-sec-0016" sec-type="COI-statement">
<title>CONFLICT OF INTERESTS</title>
<p>The authors report no relevant conflicts of interests related to the manuscript.</p>
</sec>
<sec id="mgg31234-sec-0017">
<title>AUTHOR CONTRIBUTIONS</title>
<p>Xuechao Zhao and Xiangdong Kong designed the experiments. Yanhong Wang performed the experiments. Xuechao Zhao and Shiyue Mei analyzed the data. Xuechao Zhao and Xiangdong Kong wrote the paper.</p>
</sec>
</body>
<back>
<ack id="mgg31234-sec-0015">
<title>ACKNOWLEDGMENTS</title>
<p>The authors thank the subjects and family for participating in the study.</p>
</ack>
<ref-list content-type="cited-references" id="mgg31234-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg31234-bib-0001">
<mixed-citation id="mgg31234-cit-0001" publication-type="journal">
<string-name>
<surname>Adzhubei</surname>, <given-names>I. A.</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Peshkin</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ramensky</surname>, <given-names>V. E.</given-names>
</string-name>, <string-name>
<surname>Gerasimova</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bork</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Sunyaev</surname>, <given-names>S. R.</given-names>
</string-name> (<year>2010</year>). <article-title>A method and server for predicting damaging missense mutations</article-title>. <source xml:lang="en"/>Nature Methods, <volume>7</volume>(<issue>4</issue>), <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0002">
<mixed-citation id="mgg31234-cit-0002" publication-type="journal">
<string-name>
<surname>Bassani</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Cwetsch</surname>, <given-names>A. W.</given-names>
</string-name>, <string-name>
<surname>Gerosa</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Serratto</surname>, <given-names>G. M.</given-names>
</string-name>, <string-name>
<surname>Folci</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Hall</surname>, <given-names>I. F.</given-names>
</string-name>, … <string-name>
<surname>Passafaro</surname>, <given-names>M.</given-names>
</string-name> (<year>2018</year>). <article-title>The female epilepsy protein PCDH19 is a new GABAAR‐binding partner that regulates GABAergic transmission as well as migration and morphological maturation of hippocampal neurons</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>27</volume>(<issue>6</issue>), <fpage>1027</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy019</pub-id>
<pub-id pub-id-type="pmid">29360992</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0003">
<mixed-citation id="mgg31234-cit-0003" publication-type="journal">
<string-name>
<surname>Choi</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Sims</surname>, <given-names>G. E.</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Miller</surname>, <given-names>J. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Chan</surname>, <given-names>A. P.</given-names>
</string-name> (<year>2012</year>). <article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source xml:lang="en"/>PLoS ONE, <volume>7</volume>(<issue>10</issue>), <elocation-id>e46688</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id>
<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0004">
<mixed-citation id="mgg31234-cit-0004" publication-type="journal">
<string-name>
<surname>Compagnucci</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Petrini</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Higuraschi</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Trivisano</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Specchio</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Hirose</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Terracciano</surname>, <given-names>A.</given-names>
</string-name> (<year>2015</year>). <article-title>Characterizing PCDH19 in human induced pluripotent stem cells (iPSCs) and iPSC‐derived developing neurons: Emerging role of a protein involved in controlling polarity during neurogenesis</article-title>. <source xml:lang="en"/>Oncotarget, <volume>6</volume>(<issue>29</issue>), <fpage>26804</fpage>–<lpage>26813</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.5757</pub-id>
<pub-id pub-id-type="pmid">26450854</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0005">
<mixed-citation id="mgg31234-cit-0005" publication-type="journal">
<string-name>
<surname>Davydov</surname>, <given-names>E. V.</given-names>
</string-name>, <string-name>
<surname>Goode</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Sirota</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>, <given-names>G. M.</given-names>
</string-name>, <string-name>
<surname>Sidow</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Batzoglou</surname>, <given-names>S.</given-names>
</string-name> (<year>2010</year>). <article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>. <source xml:lang="en"/>PLoS Computational Biology, <volume>6</volume>(<issue>12</issue>), <elocation-id>e1001025</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>
<pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0006">
<mixed-citation id="mgg31234-cit-0006" publication-type="journal">
<string-name>
<surname>Depienne</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Bouteiller</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Keren</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Cheuret</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Poirier</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Trouillard</surname>, <given-names>O.</given-names>
</string-name>, … <string-name>
<surname>LeGuern</surname>, <given-names>E.</given-names>
</string-name> (<year>2009</year>). <article-title>Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females</article-title>. <source xml:lang="en"/>PLoS Genetics, <volume>5</volume>(<issue>2</issue>), <elocation-id>e1000381</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000381</pub-id>
<pub-id pub-id-type="pmid">19214208</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0007">
<mixed-citation id="mgg31234-cit-0007" publication-type="journal">
<string-name>
<surname>Dibbens</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Tarpey</surname>, <given-names>P. S.</given-names>
</string-name>, <string-name>
<surname>Hynes</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Bayly</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Scheffer</surname>, <given-names>I. E.</given-names>
</string-name>, <string-name>
<surname>Smith</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Gécz</surname>, <given-names>J.</given-names>
</string-name> (<year>2008</year>). <article-title>X‐linked protocadherin 19 mutations cause female‐limited epilepsy and cognitive impairment</article-title>. <source xml:lang="en"/>Nature Genetics, <volume>40</volume>(<issue>6</issue>), <fpage>776</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1038/ng.149</pub-id>
<pub-id pub-id-type="pmid">18469813</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0008">
<mixed-citation id="mgg31234-cit-0008" publication-type="journal">
<string-name>
<surname>Jamal</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Basran</surname>, <given-names>R. K.</given-names>
</string-name>, <string-name>
<surname>Newton</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Z.</given-names>
</string-name>, &amp; <string-name>
<surname>Milunsky</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2010</year>). <article-title>Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics Part A, <volume>152A</volume>(<issue>10</issue>), <fpage>2475</fpage>–<lpage>2481</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33611</pub-id>
<pub-id pub-id-type="pmid">20830798</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0009">
<mixed-citation id="mgg31234-cit-0009" publication-type="journal">
<string-name>
<surname>Juberg</surname>, <given-names>R. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Hellman</surname>, <given-names>C. D.</given-names>
</string-name> (<year>1971</year>). <article-title>A new familial form of convulsive disorder and mental retardation limited to females</article-title>. <source xml:lang="en"/>Journal of Pediatrics, <volume>79</volume>(<issue>5</issue>), <fpage>726</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(71)80382-7</pub-id>
<pub-id pub-id-type="pmid">5116697</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0010">
<mixed-citation id="mgg31234-cit-0010" publication-type="journal">
<string-name>
<surname>Kolc</surname>, <given-names>K. L.</given-names>
</string-name>, <string-name>
<surname>Sadleir</surname>, <given-names>L. G.</given-names>
</string-name>, <string-name>
<surname>Scheffer</surname>, <given-names>I. E.</given-names>
</string-name>, <string-name>
<surname>Ivancevic</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Pham</surname>, <given-names>D. H.</given-names>
</string-name>, &amp; <string-name>
<surname>Gecz</surname>, <given-names>J.</given-names>
</string-name> (<year>2019</year>). <article-title>A systematic review and meta‐analysis of 271 PCDH19‐variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity</article-title>. <source xml:lang="en"/>Molecular Psychiatry, <volume>24</volume>(<issue>2</issue>), <fpage>241</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0066-9</pub-id>
<pub-id pub-id-type="pmid">29892053</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0011">
<mixed-citation id="mgg31234-cit-0011" publication-type="journal">
<string-name>
<surname>Kurian</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Korff</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Ranza</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Bernasconi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lubbig</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Nangia</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Bast</surname>, <given-names>T.</given-names>
</string-name> (<year>2018</year>). <article-title>Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: Case report</article-title>. <source xml:lang="en"/>Developmental Medicine and Child Neurology, <volume>60</volume>(<issue>1</issue>), <fpage>100</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13595</pub-id>
<pub-id pub-id-type="pmid">29064093</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0012">
<mixed-citation id="mgg31234-cit-0012" publication-type="journal">
<string-name>
<surname>Lindy</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Stosser</surname>, <given-names>M. B.</given-names>
</string-name>, <string-name>
<surname>Butler</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Downtain‐Pickersgill</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Shanmugham</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Retterer</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>McKnight</surname>, <given-names>D. A.</given-names>
</string-name> (<year>2018</year>). <article-title>Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders</article-title>. <source xml:lang="en"/>Epilepsia, <volume>59</volume>(<issue>5</issue>), <fpage>1062</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1111/epi.14074</pub-id>
<pub-id pub-id-type="pmid">29655203</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0013">
<mixed-citation id="mgg31234-cit-0013" publication-type="journal">
<string-name>
<surname>Liu</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, … <string-name>
<surname>Zhang</surname>, <given-names>Y.</given-names>
</string-name> (<year>2017</year>). <article-title>The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>91</volume>(<issue>1</issue>), <fpage>54</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12846</pub-id>
<pub-id pub-id-type="pmid">27527380</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0014">
<mixed-citation id="mgg31234-cit-0014" publication-type="journal">
<string-name>
<surname>Marini</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Darra</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Specchio</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Mei</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Terracciano</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Parmeggiani</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Guerrini</surname>, <given-names>R.</given-names>
</string-name> (<year>2012</year>). <article-title>Focal seizures with affective symptoms are a major feature of PCDH19 gene‐related epilepsy</article-title>. <source xml:lang="en"/>Epilepsia, <volume>53</volume>(<issue>12</issue>), <fpage>2111</fpage>–<lpage>2119</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03649.x</pub-id>
<pub-id pub-id-type="pmid">22946748</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0015">
<mixed-citation id="mgg31234-cit-0015" publication-type="journal">
<string-name>
<surname>Marini</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Mei</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Parmeggiani</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Norci</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Calado</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ferrari</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Guerrini</surname>, <given-names>R.</given-names>
</string-name> (<year>2010</year>). <article-title>Protocadherin 19 mutations in girls with infantile‐onset epilepsy</article-title>. <source xml:lang="en"/>Neurology, <volume>75</volume>(<issue>7</issue>), <fpage>646</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181ed9e67</pub-id>
<pub-id pub-id-type="pmid">20713952</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0016">
<mixed-citation id="mgg31234-cit-0016" publication-type="journal">
<string-name>
<surname>Pederick</surname>, <given-names>D. T.</given-names>
</string-name>, <string-name>
<surname>Richards</surname>, <given-names>K. L.</given-names>
</string-name>, <string-name>
<surname>Piltz</surname>, <given-names>S. G.</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Mincheva‐Tasheva</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mandelstam</surname>, <given-names>S. A.</given-names>
</string-name>, … <string-name>
<surname>Thomas</surname>, <given-names>P. Q.</given-names>
</string-name> (<year>2018</year>). <article-title>Abnormal cell sorting underlies the unique X‐linked inheritance of PCDH19 epilepsy</article-title>. <source xml:lang="en"/>Neuron, <volume>97</volume>(<issue>1</issue>), <fpage>59</fpage>–<lpage>66</lpage>.e5. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.12.005</pub-id>
<pub-id pub-id-type="pmid">29301106</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0017">
<mixed-citation id="mgg31234-cit-0017" publication-type="journal">
<string-name>
<surname>Pollard</surname>, <given-names>K. S.</given-names>
</string-name>, <string-name>
<surname>Hubisz</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Rosenbloom</surname>, <given-names>K. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Siepel</surname>, <given-names>A.</given-names>
</string-name> (<year>2010</year>). <article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>. <source xml:lang="en"/>Genome Research, <volume>20</volume>(<issue>1</issue>), <fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1101/gr.097857.109</pub-id>
<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0018">
<mixed-citation id="mgg31234-cit-0018" publication-type="journal">
<string-name>
<surname>Richards</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Bale</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bick</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gastier‐Foster</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Rehm</surname>, <given-names>H. L.</given-names>
</string-name> (<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>17</volume>(<issue>5</issue>), <fpage>405</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0019">
<mixed-citation id="mgg31234-cit-0019" publication-type="journal">
<string-name>
<surname>Schwarz</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>, <given-names>D. N.</given-names>
</string-name>, <string-name>
<surname>Schuelke</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Seelow</surname>, <given-names>D.</given-names>
</string-name> (<year>2014</year>). <article-title>MutationTaster2: Mutation prediction for the deep‐sequencing age</article-title>. <source xml:lang="en"/>Nature Methods, <volume>11</volume>(<issue>4</issue>), <fpage>361</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2890</pub-id>
<pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0020">
<mixed-citation id="mgg31234-cit-0020" publication-type="journal">
<string-name>
<surname>Siepel</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bejerano</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Pedersen</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Hinrichs</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Hou</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rosenbloom</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>Haussler</surname>, <given-names>D.</given-names>
</string-name> (<year>2005</year>). <article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title>. <source xml:lang="en"/>Genome Research, <volume>15</volume>(<issue>8</issue>), <fpage>1034</fpage>–<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1101/gr.3715005</pub-id>
<pub-id pub-id-type="pmid">16024819</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0021">
<mixed-citation id="mgg31234-cit-0021" publication-type="journal">
<string-name>
<surname>Sim</surname>, <given-names>N. L.</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Henikoff</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>, <given-names>G.</given-names>
</string-name>, &amp; <string-name>
<surname>Ng</surname>, <given-names>P. C.</given-names>
</string-name> (<year>2012</year>). <article-title>SIFT web server: Predicting effects of amino acid substitutions on proteins</article-title>. <source xml:lang="en"/>Nucleic Acids Research, <volume>40</volume>(<issue>W1</issue>), <fpage>W452</fpage>–<lpage>W457</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks539</pub-id>
<pub-id pub-id-type="pmid">22689647</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0022">
<mixed-citation id="mgg31234-cit-0022" publication-type="journal">
<string-name>
<surname>Smith</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Singhal</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>El Achkar</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Truglio</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Rosen Sheidley</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Sullivan</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Poduri</surname>, <given-names>A.</given-names>
</string-name> (<year>2018</year>). <article-title>PCDH19‐related epilepsy is associated with a broad neurodevelopmental spectrum</article-title>. <source xml:lang="en"/>Epilepsia, <volume>59</volume>(<issue>3</issue>), <fpage>679</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1111/epi.14003</pub-id>
<pub-id pub-id-type="pmid">29377098</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0023">
<mixed-citation id="mgg31234-cit-0023" publication-type="journal">
<string-name>
<surname>Terracciano</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Trivisano</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cusmai</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>De Palma</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Fusco</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Compagnucci</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Specchio</surname>, <given-names>N.</given-names>
</string-name> (<year>2016</year>). <article-title>PCDH19‐related epilepsy in two mosaic male patients</article-title>. <source xml:lang="en"/>Epilepsia, <volume>57</volume>(<issue>3</issue>), <fpage>e51</fpage>–<lpage>e55</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13295</pub-id>
<pub-id pub-id-type="pmid">26765483</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0024">
<mixed-citation id="mgg31234-cit-0024" publication-type="journal">
<string-name>
<surname>Trivisano</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pietrafusa</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Ciommo</surname>, <given-names>V. D.</given-names>
</string-name>, <string-name>
<surname>Cappelletti</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Palma</surname>, <given-names>L. D.</given-names>
</string-name>, <string-name>
<surname>Terracciano</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Specchio</surname>, <given-names>N.</given-names>
</string-name> (<year>2016</year>). <article-title>PCDH19‐related epilepsy and Dravet Syndrome: Face‐off between two early‐onset epilepsies with fever sensitivity</article-title>. <source xml:lang="en"/>Epilepsy Research, <volume>125</volume>, <fpage>32</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2016.05.015</pub-id>
<pub-id pub-id-type="pmid">27371789</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0025">
<mixed-citation id="mgg31234-cit-0025" publication-type="journal">
<string-name>
<surname>Wang</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Hakonarson</surname>, <given-names>H.</given-names>
</string-name> (<year>2010</year>). <article-title>ANNOVAR: Functional annotation of genetic variants from high‐throughput sequencing data</article-title>. <source xml:lang="en"/>Nucleic Acids Research, <volume>38</volume>(<issue>16</issue>), <fpage>e164</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
</ref>
<ref id="mgg31234-bib-0026">
<mixed-citation id="mgg31234-cit-0026" publication-type="journal">
<string-name>
<surname>Yang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Su</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Li</surname>, <given-names>B.</given-names>
</string-name> (<year>2019</year>). <article-title>Novel and de novo mutation of PCDH19 in girls clustering epilepsy</article-title>. <source xml:lang="en"/>Brain and Behavior, <volume>9</volume>(<issue>12</issue>), <elocation-id>e01455</elocation-id>
<pub-id pub-id-type="doi">10.1002/brb3.1455</pub-id>
<pub-id pub-id-type="pmid">31714027</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>